10-Jul-2003
NEL HOME, Newsletter
AIM & SCOPE
BOARD OF EDITORS
INSTRUCTIONS
Z.KLEIN AWARD for Human Ethology
CONTENTS Vol.23 Nos.5/6 Oct-Dec 2002
VOL.22, 2001
VOL.21, 2000
VOL.20, 1999
VOL.19, 1998
VOL.18, 1997
HUMAN ETHOLOGY
PREVIEW coming
PRESS ROOM
CONTACT
SUBSCRIBE order

NEUROENDOCRINOLOGY LETTERS
including Psychoneuroimmunology, Neuropsychopharmacology,
Reproductive Medicine, Chronobiology
and Human Ethology
ISSN 0172–780X


Press Room

NEL Vol.23 No.5/6,
Oct-Dec 2002

CASE STUDY
Short Title: Spastic and myocloni in a childhood neurodegenerative disease – new therapeutic options

Press Release HERE

2002; 23:387–390
pii: NEL235602C01
PMID: 12500158

[full text pdf 108kb]

 

A casuistic rationale for the treatment of spastic and myocloni
in a childhood neurodegenerative disease:
Neuronal ceroid lipofuscinosis of the type Jansky-Bielschowsky


Dr. med. Ruediger Lorenz, Brunnenstr.
54 D-34537 Bad Wildungen, GERMANY

Submitted: October 11, 2002; Accepted: October 26, 2002

Key words:
NCL; Jansky-Bielschowsky; spastic; myoclonus; epilepsy; THC; Dronabinol; Marinol; Piracetam; Zonisamide


Goal

The casuistic of a child suffering from late infantile neuronal ceroid lipofuscinosis (NCL) of the type Jansky-Bielschowsky aims to provide a description of possible therapeutic options for the severe spastic and the debilitating myocloni that occur within the context of this disorder. Moreover, it also should include a discussion of potential indications for the application of delta 9-Tetrahydrocannabinol (THC) (Dronabinol, Marinol) in childhood.


NCL

The four major variants of NCL (types Santavuori, Jansky-Bielschowsky, Spielmeyer-Vogt, and Kufs) are characterized by excessive ceroid and lipofuscin lysosomal storage in both neurons and astroglia as well as in muscle cells, the thyroid gland, pancreas, skin, conjuctiva, and lymphocytes. Whereas all four varieties are inherited in an autosomal recessive manner, they can be differentiated with respect to the defective gene involved, the material stored at the cellular level, their light microscopic findings, clinic, and onset of illness.
The late infantile NCL is a lysosomal storage disease that can be traced to a defect in the formation of the lysosomal pepstatin-insensitive carboxypeptidase, which results in storage of the mitochondrial ATP-synthase subunit C, a component of the internal mitochondrion membrane [1]. Storage occurs in the form of wafer-thin layers and occasionally takes on a fingerprint-like configuration. Magnetic resonance imaging reveals a generalized brain atrophy that is especially marked in the cerebellum. In PET, a rapidly progressive degeneration of the brain tissue, accompanied by cortical and subcortical (thalamic) hypometabolismus, can be detected [2]. Clinically, the patients present with epileptic seizures as well as myocloni of a non-epileptic genesis originating for the most part in the cortex [3], which are capable of culminating in clonic-tonic seizures [4], loss of visual acuity and speech, ataxia, and spastic. Death occurs in late childhood.

... ...

__________________________________________________________
Copyright © Neuroendocrinology Letters 2002
All rights reserved. No part may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or ortherwise, without prior written permission from the Editor-in-Chief.